Attached files

file filename
EX-23.1 - EXHIBIT 23.1 - Travere Therapeutics, Inc.t1500483_ex23-1.htm
EX-31.2 - EXHIBIT 31.2 - Travere Therapeutics, Inc.t1500483_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - Travere Therapeutics, Inc.t1500483_ex32-1.htm
EX-23.2 - EXHIBIT 23.2 - Travere Therapeutics, Inc.t1500483_ex23-2.htm
EX-31.1 - EXHIBIT 31.1 - Travere Therapeutics, Inc.t1500483_ex31-1.htm
EX-10.28 - EXHIBIT 10.28 - Travere Therapeutics, Inc.t1500483_ex10-28.htm
EX-10.27 - EXHIBIT 10.27 - Travere Therapeutics, Inc.t1500483_ex10-27.htm
EX-10.25 - EXHIBIT 10.25 - Travere Therapeutics, Inc.t1500483_ex10-25.htm
EX-10.26 - EXHIBIT 10.26 - Travere Therapeutics, Inc.t1500483_ex10-26.htm
EXCEL - IDEA: XBRL DOCUMENT - Travere Therapeutics, Inc.Financial_Report.xls
10-K - FORM 10-K - Travere Therapeutics, Inc.t1500483_10k.htm
EX-32.2 - EXHIBIT 32.2 - Travere Therapeutics, Inc.t1500483_ex32-2.htm

 

Exhibit 21.1

 

RETROPHIN, INC.

LIST OF SUBSIDIARIES

 

No.   

Name

1   Retrophin Pharmaceutical, Inc.
2   Retrophin Therapeutics I, Inc.
3   Retrophin Therapeutics II, Inc.
4   Retrophin Europe Ltd
5   Retrophin International Holdings Ltd
6   RTRX International CV
7   Retrophin Therapeutics International LLC
8   Retrophin Therapeutics International Cooperatief
9   US LLC 2
10   Retrophin Therapeutics International I, BV
11   Retrophin Therapeutics International II, BV